Surgical Science Sweden AB Working Capital to Net Assets Ratio

Latest as of June 2026: 21.2%

Surgical Science Sweden AB working capital to net assets ratio. Surgical Science Sweden AB (SUS) has a Working Capital to Net Assets ratio of 21.2% as of June 2026. Working capital of Skr963.07 Million (current assets of Skr1.26 Billion minus current liabilities of Skr297.02 Million) is measured against net assets of Skr4.55 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check SUS tangible net assets ratio to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

21.2%
Working Capital / Net Assets

Working Capital

Skr963.07 Million
SEK

Current Assets

Skr1.26 Billion
SEK

Current Liabilities

Skr297.02 Million
SEK

Working Capital to Net Assets Ratio of Surgical Science Sweden AB (2014–2025)

Working capital to net assets ratio of Surgical Science Sweden AB from 2014 to 2025. This chart shows how Surgical Science Sweden AB's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 21.2%, reflecting working capital of Skr963.07 Million against net assets of Skr4.55 Billion SEK. See defensive interval ratio of Surgical Science Sweden AB to measure how many days the company can operate on defensive assets alone.

Surgical Science Sweden AB Working Capital to Net Assets Ratio by Year (2014–2025)

Surgical Science Sweden AB working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Surgical Science Sweden AB from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Surgical Science Sweden AB balance sheet assets.

Year WC/NA Ratio Working Capital (SEK) Net Assets Current Assets Current Liabilities Change (pp)
2025 20.9% Skr893.55 Million Skr4.27 Billion Skr1.18 Billion Skr291.14 Million ▲ +2.0 pp
2024 18.9% Skr913.28 Million Skr4.83 Billion Skr1.43 Billion Skr512.72 Million ▲ +1.5 pp
2023 17.4% Skr756.25 Million Skr4.35 Billion Skr991.19 Million Skr234.94 Million ▲ +5.1 pp
2022 12.3% Skr520.46 Million Skr4.24 Billion Skr826.37 Million Skr305.91 Million ▲ +1.6 pp
2021 10.7% Skr384.53 Million Skr3.59 Billion Skr616.91 Million Skr232.38 Million ▼ -13.2 pp
2020 23.9% Skr102.12 Million Skr427.05 Million Skr133.39 Million Skr31.28 Million ▲ +5.7 pp
2019 18.2% Skr73.19 Million Skr401.68 Million Skr112.77 Million Skr39.58 Million ▼ -37.1 pp
2018 55.3% Skr43.90 Million Skr79.38 Million Skr59.81 Million Skr15.90 Million ▼ -1.9 pp
2017 57.2% Skr48.91 Million Skr85.52 Million Skr59.55 Million Skr10.64 Million ▲ +34.4 pp
2016 22.8% Skr5.10 Million Skr22.40 Million Skr27.20 Million Skr22.10 Million ▼ -35.4 pp
2015 58.2% Skr11.40 Million Skr19.60 Million Skr24.80 Million Skr13.40 Million ▲ +34.0 pp
2014 24.1% Skr9.09 Million Skr37.66 Million Skr20.76 Million Skr11.67 Million —
pp = percentage points